Abbott Vascular
3200 Lakeside Dr.
Santa Clara, CA 95054
USA
Phone:
(408) 845-3000
Product Categories:
Related Content
Abbott's Absorb bioresorbable stent
Feature | December 31, 2014 | Dave Fornell
Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely...
Feature | November 11, 2014
Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announce clinical...
Technology | November 04, 2014
The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus-eluting coronary stents...
Feature | November 03, 2014 | Dave Fornell
There are several hemostasis devices that can help cath labs improve efficiency by reducing nursing time in the recov
Topera's FIRMap diagnostic catheter produces dynamic electrical maps to identify rotors, the specific areas within the heart acting as a sustaining mechanism for atrial fibrillation.
Feature | October 29, 2014
Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device company focused...
Werner Dyer, who is now 92, had his TAVR last year and was able to rejoin his bowling league and now bowls four times a week.
News | October 27, 2014
Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency....
Feature | October 08, 2014
October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb...
Videos | Stents Bioresorbable | September 24, 2014
DAIC Editor, Dave Fornell, interviews Jim Hermiller, M.D., FACC, director of interventional cardiology, St.
Feature | September 24, 2014
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective, randomized,...
Abbott has spearheaded bioresorbable stent technology with the development with its BVS. By far the BVS has the most clinical experience, with more than 13,000 patients around the world having been treated with the device.
Feature | Stents Bioresorbable | September 03, 2014 | Dave Fornell
A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and...
